-
Je něco špatně v tomto záznamu ?
The Czech Surveillance System for Invasive Pneumococcal Disease, 2008-2013: A Follow-Up Assessment and Sensitivity Estimation
NK. Stock, M. Maly, H. Sebestova, H. Orlikova, J. Kozakova, P. Krizova,
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články, práce podpořená grantem
NLK
Directory of Open Access Journals
od 2006
Free Medical Journals
od 2006
Public Library of Science (PLoS)
od 2006
PubMed Central
od 2006
Europe PubMed Central
od 2006
ProQuest Central
od 2006-12-01
Open Access Digital Library
od 2006-10-01
Open Access Digital Library
od 2006-01-01
Open Access Digital Library
od 2006-01-01
Medline Complete (EBSCOhost)
od 2008-01-01
Nursing & Allied Health Database (ProQuest)
od 2006-12-01
Health & Medicine (ProQuest)
od 2006-12-01
Public Health Database (ProQuest)
od 2006-12-01
ROAD: Directory of Open Access Scholarly Resources
od 2006
- MeSH
- biostatistika MeSH
- epidemiologické monitorování MeSH
- hromadná vakcinace statistika a číselné údaje MeSH
- incidence MeSH
- lidé MeSH
- následné studie MeSH
- očkovací programy statistika a číselné údaje MeSH
- očkovací schéma MeSH
- pneumokokové infekce epidemiologie prevence a kontrola MeSH
- pneumokokové vakcíny aplikace a dávkování MeSH
- programy národního zdraví statistika a číselné údaje MeSH
- vakcíny konjugované aplikace a dávkování MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- Geografické názvy
- Česká republika MeSH
BACKGROUND: Invasive pneumococcal disease (IPD) is caused by Streptococcus pneumoniae and mostly presents as pneumonia, sepsis or meningitis. A notable portion of IPD cases is vaccine preventable and the pneumococcal conjugate vaccine (PCV) was introduced into the routine childhood immunization programs in many countries during the last decades. OBJECTIVES: Before PCV introduction in the Czech Republic in 2010, a national surveillance system for IPD was implemented in 2008 and further improved in 2011. In this study, we describe the new surveillance system for the first time and measure its sensitivity between 2010 and 2013 using the capture-recapture method. Furthermore, we describe the recent epidemiological trend of IPD, taking sensitivity estimates into account. RESULTS AND CONCLUSIONS: Between 2010 and 2013 the estimated sensitivity of the overall IPD surveillance increased from 81% to 99%. The sensitivity of individual reporting sources increased from 72% to 87% for the laboratory system and from 31% to 89% for the epidemiological notification system. Crucial for this improvement was the introduction of quarterly report reminders in 2011. Due to positive source dependency, the presented sensitivity estimates are most probably overestimated and reflect the upper limit of reporting completeness. Stratification showed variation in sensitivity of reporting particularly according to region. An effect of the PVC vaccination in the Czech Republic is visible in the incidence of IPD in target age groups (<5 y). This influence was not evident in the total IPD incidence and may interfere with increasing sensitivity of reporting. In 2013, an increase in the IPD incidence was observed. This finding requires further observation and a detailed vaccine impact analysis is needed to assess the current immunization strategy.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc16020608
- 003
- CZ-PrNML
- 005
- 20171116131029.0
- 007
- ta
- 008
- 160722s2015 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1371/journal.pone.0131117 $2 doi
- 024 7_
- $a 10.1371/journal.pone.0131117 $2 doi
- 035 __
- $a (PubMed)26125583
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Stock, Nina Katharina $u National Institute of Public Health (NIPH), Prague, Czech Republic; European Program for Public Health Microbiology (EUPHEM), ECDC, Stockholm, Sweden.
- 245 14
- $a The Czech Surveillance System for Invasive Pneumococcal Disease, 2008-2013: A Follow-Up Assessment and Sensitivity Estimation / $c NK. Stock, M. Maly, H. Sebestova, H. Orlikova, J. Kozakova, P. Krizova,
- 520 9_
- $a BACKGROUND: Invasive pneumococcal disease (IPD) is caused by Streptococcus pneumoniae and mostly presents as pneumonia, sepsis or meningitis. A notable portion of IPD cases is vaccine preventable and the pneumococcal conjugate vaccine (PCV) was introduced into the routine childhood immunization programs in many countries during the last decades. OBJECTIVES: Before PCV introduction in the Czech Republic in 2010, a national surveillance system for IPD was implemented in 2008 and further improved in 2011. In this study, we describe the new surveillance system for the first time and measure its sensitivity between 2010 and 2013 using the capture-recapture method. Furthermore, we describe the recent epidemiological trend of IPD, taking sensitivity estimates into account. RESULTS AND CONCLUSIONS: Between 2010 and 2013 the estimated sensitivity of the overall IPD surveillance increased from 81% to 99%. The sensitivity of individual reporting sources increased from 72% to 87% for the laboratory system and from 31% to 89% for the epidemiological notification system. Crucial for this improvement was the introduction of quarterly report reminders in 2011. Due to positive source dependency, the presented sensitivity estimates are most probably overestimated and reflect the upper limit of reporting completeness. Stratification showed variation in sensitivity of reporting particularly according to region. An effect of the PVC vaccination in the Czech Republic is visible in the incidence of IPD in target age groups (<5 y). This influence was not evident in the total IPD incidence and may interfere with increasing sensitivity of reporting. In 2013, an increase in the IPD incidence was observed. This finding requires further observation and a detailed vaccine impact analysis is needed to assess the current immunization strategy.
- 650 _2
- $a biostatistika $7 D056808
- 650 _2
- $a epidemiologické monitorování $7 D062665
- 650 _2
- $a následné studie $7 D005500
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a očkovací programy $x statistika a číselné údaje $7 D017589
- 650 _2
- $a očkovací schéma $7 D007115
- 650 _2
- $a incidence $7 D015994
- 650 _2
- $a hromadná vakcinace $x statistika a číselné údaje $7 D032541
- 650 _2
- $a programy národního zdraví $x statistika a číselné údaje $7 D009313
- 650 _2
- $a pneumokokové infekce $x epidemiologie $x prevence a kontrola $7 D011008
- 650 _2
- $a pneumokokové vakcíny $x aplikace a dávkování $7 D022242
- 650 _2
- $a vakcíny konjugované $x aplikace a dávkování $7 D018074
- 651 _2
- $a Česká republika $x epidemiologie $7 D018153
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Maly, Marek $u National Institute of Public Health (NIPH), Prague, Czech Republic.
- 700 1_
- $a Sebestova, Helena $u National Institute of Public Health (NIPH), Prague, Czech Republic.
- 700 1_
- $a Orlíková, Hana, $d 1965- $7 xx0218806 $u National Institute of Public Health (NIPH), Prague, Czech Republic.
- 700 1_
- $a Kozakova, Jana $u National Institute of Public Health (NIPH), Prague, Czech Republic.
- 700 1_
- $a Krizova, Pavla $u National Institute of Public Health (NIPH), Prague, Czech Republic.
- 773 0_
- $w MED00180950 $t PloS one $x 1932-6203 $g Roč. 10, č. 6 (2015), s. e0131117
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/26125583 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20160722 $b ABA008
- 991 __
- $a 20171116131141 $b ABA008
- 999 __
- $a ok $b bmc $g 1155278 $s 945136
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2015 $b 10 $c 6 $d e0131117 $e 20150630 $i 1932-6203 $m PLoS One $n PLoS One $x MED00180950
- LZP __
- $a Pubmed-20160722